ILMN Illumina
- 112.480
- -1.980-1.73%
Illumina News
Most Attractive Short-term Overwriting Stocks for June Expiration - Goldman
Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events.
Daiwa Securities Adjusts Price Target on Illumina to $120 From $133
Illumina (ILMN) has an average rating of outperform and price targets ranging from $100 to $253, according to analysts polled by Capital IQ. Price: 115.26, Change: -0.32, Percent Change: -0.28
Illumina To Webcast Upcoming Investor Conference
SAN DIEGO, May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:Bernstein's 40th Annual Strategic Decisi
10 Health Care Stocks With Whale Alerts In Today's Session
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript)
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript)
TD Cowen Sticks to Its Hold Rating for Illumina (ILMN)
GRAIL to Host Capital Markets Day
GRAIL Leadership to Outline Early Cancer Detection Market Opportunity, Business Strategy, and Financial Profile GRAIL, LLC., a healthcare company whose mission is to detect cancer early when it can be cured, today
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Illumina fair value estimate is US$92.90 Current share price of US$111 suggests Illumina is potentially trading close to its fair value Th
Research Alert: CFRA Lowers View On Shares Of Illumina, Inc. To Sell From Hold
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our view on shares of ILMN to S
Illumina Unusual Options Activity For May 07
Investors with a lot of money to spend have taken a bearish stance on Illumina (NASDAQ:ILMN).And retail traders should know.We noticed this today when the trades showed up on publicly available option
Stephens & Co. : The Illumina (ILMN.US) rating was reaffirmed and adjusted from an increase in holdings to an increase in holdings rating, with a target price of $170.00.
Stephens & Co. : The Illumina (ILMN.US) rating was reaffirmed and adjusted from an increase in holdings to an increase in holdings rating, with a target price of $170.00.
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Stephens & Co. analyst Mason Carrico reiterates Illumina (NASDAQ:ILMN) with a Overweight and maintains $170 price target.
Illumina Files Registration Statement for Planned GRAIL Divestiture
Illumina (ILMN) said Monday that it filed a Form 10 registration statement with the US Securities and Exchange Commission for the planned divestiture of its GRAIL business, as required for a capital m
Illumina Picks Spin-off Option for Grail Divestment
Illumina: Filing Is a Necessary Step for a Cap Markets Transaction, However, It Isn't an Indication of the Means by Which Illumina Will Ultimately Divest GRAIL >ILMN
Illumina: Filing Is a Necessary Step for a Cap Markets Transaction, However, It Isn't an Indication of the Means by Which Illumina Will Ultimately Divest GRAIL >ILMN
Illumina: Form 10 Includes Detailed Info About GRAIL, Including Historic Fincl Info, a Description of GRAIL's Business and Strategy, and Other Legal and Fincl Disclosures >ILMN
Illumina: Form 10 Includes Detailed Info About GRAIL, Including Historic Fincl Info, a Description of GRAIL's Business and Strategy, and Other Legal and Fincl Disclosures >ILMN
Illumina: Files Form 10 Registration Statement With SEC Ahead of Planned Divestiture of GRAIL
Illumina: Files Form 10 Registration Statement With SEC Ahead of Planned Divestiture of GRAIL
Illumina Price Target Cut to $176.00/Share From $185.00 by Scotiabank
Illumina Price Target Cut to $176.00/Share From $185.00 by Scotiabank
Illumina Is Maintained at Sector Outperform by Scotiabank
Illumina Is Maintained at Sector Outperform by Scotiabank
Scotiabank: Maintaining the Illumina (ILMN.US) rating, adjusted from outperforming the market to outperforming the market rating, and the target price was adjusted from $185.00 to $176.00.
Scotiabank: Maintaining the Illumina (ILMN.US) rating, adjusted from outperforming the market to outperforming the market rating, and the target price was adjusted from $185.00 to $176.00.
Analysis
Price Target
No Data
